[Federal Register Volume 61, Number 201 (Wednesday, October 16, 1996)]
[Notices]
[Page 53931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-26410]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, Public Health Service, DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The invention listed below is owned by an agency of the U.S. 
Government and is available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federally funded research and development.

ADDRESSES: Licensing information and a copy of the U.S. patent 
application referenced below may be obtained by contacting George H. 
Keller, Ph.D., at the Office of Technology Transfer, National 
Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, 
Maryland 20852-3804 (telephone 301/496-7735 ext 246; fax 301/402-0220). 
A signed Confidential Disclosure Agreement will be required to receive 
a copy of the patent application.

A Method of Detecting Transmissible Spongiform Encephalopathies

G. Hsich, C.J. Gibbs, K. Kenney, M.G. Harrington (NINDS)
Filed 5 Apr 96
DHHS Reference No. E-055-96/0

    Improved assays for the detection of transmissible spongiform 
encephalopathies (TSEs) in humans and non-human mammals have been 
developed. The assays involve detecting the presence or absence of 14-
3-3 proteins in cerebrospinal fluid. Elevated levels of these proteins 
are indicative of TSEs, in particular Creutzfeldt-Jacob disease in 
humans and animals with these diseases. This invention is available for 
licensing on a non-exclusive basis.

    Dated: October 2, 1996.
Barbara M. McGarey,
Deputy Director, Office of Technology Transfer.
[FR Doc. 96-26410 Filed 10-15-96; 8:45 am]
BILLING CODE 4140-01-M